Several studies have demonstrated increased percentages of FOXP3+ CD4+ T cells in the periphery and reduced organ-specific autoimmune disease susceptibility, including T1D in the NOD model (52–54). This evidence concerns the gene CD4 and type 1 diabetes mellitus.